Michael King Schultz

Viewpoint Molecular Targeting, Inc.

$7,092,453

Attributed

$8,264,067

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2M · FY2020–24

$2M$1.5M$1M$500K$0

'20

'21

'22

'23

'24

Funding mix

By agency

NIH$8,264,067 · 5

By mechanism

R44$7,872,514 · 4

R42$391,553 · 1

Top collaborators

Alan Brent Packard2 shared
Jacob Houghton1 shared

Most similar at Viewpoint Molecular Targeting, Inc.

Same institution · by research overlap

Frances L Johnson$2,780,400

Others in their field

Other Emerging Leaders on “Small Business Innovation Research Grant”

Gary Fanger · Rise Therapeutics, Llc$23,463,293
Molly Wasko · University Of Alabama At Birmingham$18,764,568
Ashkan Vaziri · Biosensics, Llc$17,149,241
Bryan L McLaughlin · Micro-Leads, Inc.$11,109,320
Federico Cividini · Cardiac Rsk3 Inhibitors, Llc$10,485,488
Matthew Golden · Maphabit, Inc.$8,701,960

Research focus

Small Business Innovation Research GrantDosimetryResponseProductionParticle TherapyRadiopharmaceuticalsAlpha ParticlesRadionuclide TherapyPublished CommentSecurePeptidesIn Complete RemissionIowaClinicNeuroendocrine TumorsResearch And DevelopmentUniversitiesDoseClinical TrialsKidneyInnovationImproved OutcomeImageFormulation